Why Licensing Matters for Your Weight Loss Journey
Understanding the Critical Difference Between Wegovy and Ozempic Licensing
The primary difference between Wegovy and Ozempic lies in their licensing and legal use for weight management. Both treatments contain semaglutide, a GLP-1 receptor agonist, but Wegovy is specifically licensed by the MHRA for weight management in adults with BMI ≥30, or BMI ≥27 with weight-related comorbidities. Ozempic, conversely, is licensed exclusively for type 2 diabetes management and cannot legally be prescribed for weight loss in the UK.
This licensing difference is crucial for patient safety and legal compliance. When comparing Wegovy vs Ozempic for weight management, only Wegovy has undergone the comprehensive STEP clinical trial programme specifically for obesity treatment. NICE guidelines (TA875) recommend Wegovy as a prescription-only medicine for weight management, whilst using Wegovy for weight management remains off-label and legally problematic for UK prescribers.
Wegovy Pricing and Value for Prescription Weight Loss Treatment
Understanding the difference between Wegovy and Ozempic costs reveals why proper licensing matters for value. Wegovy is available through EverydayMeds from £79.99 for the 0.25mg starter dose, with new customers applying code FIRST40 at checkout. Our Intro Duo bundle (0.25mg & 0.5mg) costs £169.99, providing your first two months of treatment in one convenient order.
The structured dosing programme includes 0.5mg (£94.99), 1mg (£99.99), 1.7mg (£139.99), and the 2.4mg maintenance dose (£209.99). Our Progress Trio bundle offers 0.5mg, 1mg, and 1.7mg doses for £369.99, whilst returning customers benefit from code DOSE25 applied at checkout. This transparent pricing structure reflects licensed treatment costs, unlike uncertain pricing for off-label alternatives.
Clinical Evidence Supporting the Wegovy vs Ozempic Weight Loss Difference
The difference between Wegovy and Ozempic clinical evidence lies in purpose-built weight management trials. In the landmark STEP 1 trial (Wilding et al., NEJM, 2021), patients taking Wegovy alongside diet and exercise achieved approximately 15% average weight loss at 68 weeks, compared to 2.4% with placebo. The STEP programme specifically evaluated semaglutide for obesity treatment across diverse patient populations.
STEP 5 demonstrated sustained weight management over two years, with patients maintaining approximately clinically studied weight loss. The recent SELECT cardiovascular outcomes trial showed a 20% reduction in major cardiovascular events, highlighting benefits beyond weight management. These obesity-specific trials distinguish Wegovy's evidence base from Ozempic's diabetes-focused research programme.
How Wegovy Works as a Licensed Weight Management Treatment
Wegovy functions as a GLP-1 receptor agonist, mimicking natural hormones that regulate appetite and food intake. The treatment works on brain appetite centres, helping reduce food cravings and promoting feelings of fullness after smaller meals. Unlike quick-fix solutions, Wegovy supports sustainable weight management by addressing the biological mechanisms underlying obesity. This once-weekly injection is designed to be used alongside a reduced-calorie diet and increased physical activity. The treatment's mechanism explains why proper dosing and medical supervision are essential for safe, effective outcomes.
EverydayMeds Ordering Process for Licensed Wegovy Treatment
Accessing licensed Wegovy through EverydayMeds involves a streamlined 3-minute online clinical assessment, ensuring appropriate prescribing for your individual circumstances. Our prescribers review your assessment within 3 working days (or 24 hours with express service), confirming eligibility for this prescription-only medicine. Once approved, your treatment is dispatched via next-day delivery using temperature-controlled, cold-chain logistics. This process ensures you receive genuine, licensed Wegovy rather than unlicensed alternatives. Our GPhC-registered pharmacy (#9012878) maintains full regulatory compliance throughout your treatment journey.
Storage and Practical Considerations for Wegovy Treatment
Wegovy requires refrigeration at 2-8°C before first use, but offers practical advantages once in use. The FlexTouch pen can remain at room temperature below 30°C for up to 6 weeks, providing flexibility for travel and daily routines. This storage advantage distinguishes Wegovy from some alternatives that require more restrictive temperature control. The dose escalation programme begins with 0.25mg for weeks 1-4, progressing through 0.5mg, 1mg, and 1.7mg before reaching the 2.4mg maintenance dose. Each pre-filled pen contains four doses, administered once weekly via subcutaneous injection.
Legal and Safety Implications of Choosing Licensed Wegovy Over Ozempic
The regulatory difference between Wegovy and Wegovy for weight management extends beyond simple licensing to encompass patient safety and treatment oversight. Licensed Wegovy prescriptions include appropriate monitoring protocols, dose escalation schedules, and safety information specific to weight management patients. Using Ozempic off-label for weight loss may lack these safeguards, potentially compromising treatment outcomes and patient wellbeing.
MHRA additional monitoring (Black Triangle ▼) applies to Wegovy, ensuring comprehensive post-marketing surveillance of this newer treatment indication. This regulatory oversight provides additional confidence in treatment safety compared to off-label alternatives. Professional medical bodies recognise the importance of using appropriately licensed treatments for their intended purposes.
Starting Your Licensed Weight Management Journey with EverydayMeds
Beginning treatment with licensed Wegovy represents a commitment to evidence-based, professionally supervised weight management rather than quick fixes or unlicensed alternatives. Our clinical team at EverydayMeds ensures you understand the difference between Wegovy and Ozempic, supporting informed treatment decisions. New customers benefit from code FIRST40, whilst returning customers use DOSE25, both applied at checkout for transparent pricing. Your prescription-only medicine arrives with comprehensive support materials and access to ongoing clinical guidance. Take the first step toward licensed, effective weight management by completing our brief online assessment today. Start your Wegovy assessment here.
Reviewed by the EverydayMeds Clinical Team · GPhC #9012878 · Last updated February 2026
